Distinguished in Developmental Dysphasia Familial

Merce Boada

Madrid, MD, ES 
Distinguished in Developmental Dysphasia Familial
Madrid, MD, ES 
OverviewLocationsClinical Research

Overview

Merce Boada practices in Madrid, Spain. Boada is rated as a Distinguished expert by MediFind in the treatment of Developmental Dysphasia Familial. Their top areas of expertise are Alzheimer's Disease, Dementia, Developmental Dysphasia Familial, Endoscopy, and Septoplasty.

Their clinical research consists of co-authoring 306 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 31 articles in the study of Developmental Dysphasia Familial.

Locations

Madrid, MD, Spain
Other Locations
Barcelona, CT, Spain
El Pardo, MD 28029, Spain
Sevilla, AN, Spain
Esplugues De Llobregat, CT, Spain
Spain
Terrassa, CT, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 2b Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel Group Dose Finding, Safety, Tolerability and Efficacy Study of PQ912 in Subjects With MCI and Mild Dementia Due to Alzheimer's Disease.
A Phase 2b Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel Group Dose Finding, Safety, Tolerability and Efficacy Study of PQ912 in Subjects With MCI and Mild Dementia Due to Alzheimer's Disease.
Enrollment Status: Completed
Publish Date: March 12, 2024
Intervention Type: Drug
Study Drug: PQ912 Glutaminyl Cyclase Enzyme Inhibitor
Study Phase: Phase 2
GAIN Trial: A Randomized, Double-Blind, Placebo-Controlled Study of COR388 in Subjects With Alzheimer's Disease
GAIN Trial: A Randomized, Double-Blind, Placebo-Controlled Study of COR388 in Subjects With Alzheimer's Disease
Enrollment Status: Completed
Publish Date: February 23, 2023
Intervention Type: Drug
Study Drug: COR388
Study Phase: Phase 2/Phase 3
View 1 Less Clinical Trial

306 Total Publications

Cardiovascular health and cognition in older adults: Variations across recruitment models and European countries in the MOPEAD project.
Cardiovascular health and cognition in older adults: Variations across recruitment models and European countries in the MOPEAD project.
Journal: Journal of Alzheimer's disease : JAD
Published: September 03, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Boada's expertise for a condition
ConditionClose
View All 20 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile